FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2924765283> ?p ?o ?g. }

• W2924765283 endingPage "728" @default.
• W2924765283 startingPage "715" @default.
• W2924765283 abstract "Background: Tyrosinase is involved in the melanin biosynthesis and the abnormal accumulation of melanin pigments leading to hyperpigmentation disorders. Controlling the melanogenesis could be an important strategy for treating abnormal pigmentation. Methods: In the present study, a series of amide derivatives (3a-e and 5a-e) were synthesized aiming to inhibit tyrosinase activity and melanin production. All derivatives were screened for tyrosinase inhibition in a cell-free system. The possible interactions of amide derivatives with tyrosinase enzyme and effect of these interactions on tyrosinase structure were checked by molecular docking in silico and by Circular Dichroism (CD) studies, respectively. The most potent amide derivative (5c) based on cell-free experiments, was further tested for cellular ROS inhibition and for tyrosinase activity using mouse skin melanoma (B16F10) cells. Results: The tyrosinase inhibitory concentration (IC50) for tested compounds was observed between the range of 68 to 0.0029 µg/ml with a lowest IC50 value of compound 5c which outperforms the reference arbutin and kojic acid. The cellular tyrosinase activity and melanin quantification assay demonstrate that 15µg/ml of 5c attenuates 36% tyrosinase, 24% melanin content of B16F10 cells without significant cell toxicity. Moreover, the zebrafish in vivo assay reveals that 5c effectively reduces melanogenesis without perceptible toxicity. Furthermore, the molecular docking demonstrates that compound 5c interacts with copper ions and multiple amino acids in the active site of tyrosinase with best glide score (-5.387 kcal/mol), essential for mushroom tyrosinase inhibition and the ability to diminish the melanin synthesis in-vitro and in-vivo. Conclusion: Thus, we propose compound 5c as a potential candidate to control tyrosinase rooted hyperpigmentation in the future." @default.
• W2924765283 created "2019-04-01" @default.
• W2924765283 creator A5000364017 @default.
• W2924765283 creator A5000955664 @default.
• W2924765283 creator A5032593522 @default.
• W2924765283 creator A5045133688 @default.
• W2924765283 creator A5048482307 @default.
• W2924765283 creator A5058065492 @default.
• W2924765283 creator A5065237232 @default.
• W2924765283 creator A5073736797 @default.
• W2924765283 creator A5078947807 @default.
• W2924765283 creator A5084081155 @default.
• W2924765283 date "2019-10-14" @default.
• W2924765283 modified "2023-10-14" @default.
• W2924765283 title "Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies" @default.
• W2924765283 cites W1453127785 @default.
• W2924765283 cites W1601897860 @default.
• W2924765283 cites W1966989031 @default.
• W2924765283 cites W1972366945 @default.
• W2924765283 cites W1975557156 @default.
• W2924765283 cites W1978432995 @default.
• W2924765283 cites W1983770371 @default.
• W2924765283 cites W1991376505 @default.
• W2924765283 cites W1993234572 @default.
• W2924765283 cites W1999017424 @default.
• W2924765283 cites W2003475384 @default.
• W2924765283 cites W2005338518 @default.
• W2924765283 cites W2011568347 @default.
• W2924765283 cites W2019405618 @default.
• W2924765283 cites W2024877560 @default.
• W2924765283 cites W2025548094 @default.
• W2924765283 cites W2029863065 @default.
• W2924765283 cites W2031838201 @default.
• W2924765283 cites W2032399175 @default.
• W2924765283 cites W2032805441 @default.
• W2924765283 cites W2043597629 @default.
• W2924765283 cites W2049198031 @default.
• W2924765283 cites W2054364004 @default.
• W2924765283 cites W2056742778 @default.
• W2924765283 cites W2059212458 @default.
• W2924765283 cites W2067560048 @default.
• W2924765283 cites W2070564169 @default.
• W2924765283 cites W2074725843 @default.
• W2924765283 cites W2081073410 @default.
• W2924765283 cites W2081462173 @default.
• W2924765283 cites W2083658535 @default.
• W2924765283 cites W2087604432 @default.
• W2924765283 cites W2090139728 @default.
• W2924765283 cites W2093289715 @default.
• W2924765283 cites W2095145930 @default.
• W2924765283 cites W2106293327 @default.
• W2924765283 cites W2106311948 @default.
• W2924765283 cites W2111164125 @default.
• W2924765283 cites W2113445505 @default.
• W2924765283 cites W2121602035 @default.
• W2924765283 cites W2132744240 @default.
• W2924765283 cites W2133768972 @default.
• W2924765283 cites W2138334551 @default.
• W2924765283 cites W2153649171 @default.
• W2924765283 cites W2158113006 @default.
• W2924765283 cites W2160694733 @default.
• W2924765283 cites W2169636536 @default.
• W2924765283 cites W2179764028 @default.
• W2924765283 cites W2187528730 @default.
• W2924765283 cites W2323823141 @default.
• W2924765283 cites W2951700707 @default.
• W2924765283 cites W4242349231 @default.
• W2924765283 cites W791415813 @default.
• W2924765283 doi "https://doi.org/10.2174/1573406415666190319101329" @default.
• W2924765283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30892163" @default.
• W2924765283 hasPublicationYear "2019" @default.
• W2924765283 type Work @default.
• W2924765283 sameAs 2924765283 @default.
• W2924765283 citedByCount "9" @default.
• W2924765283 countsByYear W29247652832020 @default.
• W2924765283 countsByYear W29247652832021 @default.
• W2924765283 countsByYear W29247652832022 @default.
• W2924765283 crossrefType "journal-article" @default.
• W2924765283 hasAuthorship W2924765283A5000364017 @default.
• W2924765283 hasAuthorship W2924765283A5000955664 @default.
• W2924765283 hasAuthorship W2924765283A5032593522 @default.
• W2924765283 hasAuthorship W2924765283A5045133688 @default.
• W2924765283 hasAuthorship W2924765283A5048482307 @default.
• W2924765283 hasAuthorship W2924765283A5058065492 @default.
• W2924765283 hasAuthorship W2924765283A5065237232 @default.
• W2924765283 hasAuthorship W2924765283A5073736797 @default.
• W2924765283 hasAuthorship W2924765283A5078947807 @default.
• W2924765283 hasAuthorship W2924765283A5084081155 @default.
• W2924765283 hasConcept C107538193 @default.
• W2924765283 hasConcept C150903083 @default.
• W2924765283 hasConcept C159110408 @default.
• W2924765283 hasConcept C181199279 @default.
• W2924765283 hasConcept C185592680 @default.
• W2924765283 hasConcept C202751555 @default.
• W2924765283 hasConcept C207001950 @default.
• W2924765283 hasConcept C2777752497 @default.
• W2924765283 hasConcept C2779538156 @default.
• W2924765283 hasConcept C2781424683 @default.

• next